Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis III: Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Hypersensitivity Reactions: Cytolytic Reactions
Hypersensitivity Reactions: Immune-Complex Reactions
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: May 14, 2026

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
Published on: May 23, 2025
Atul Singla1, Mia J Sullivan, Grace Lee
1Cleveland Clinic Foundation, Cleveland, Ohio; Platelet & Neutrophil Immunology Laboratory, Blood Research Institute, BloodCenter of Wisconsin, Milwaukee, Wisconsin; Division of Hematology, Duke University Medical Center, Durham, North Carolina; Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin.
A rare, severe thrombocytopenia after protamine administration was caused by a unique antibody targeting protamine-heparin complexes. This discovery defines a new mechanism for drug-induced immune thrombocytopenia.
Area of Science:
Background: